Friday, July 10, 2026

Drug profile · INN

anti-melanoma mab fragments

anti-melanoma mab fragments (TECNEMAB K1) is a diagnostic agent.

EMA: withdrawn Various (V09) V09IA02
Patents linked 0
Pipeline programs 61
News articles 0
Drug details — anti-melanoma mab fragments
Class
Various (V09)
Route
Patents
0
Programs
61
Data quality
0.83

Quick answer

anti-melanoma mab fragments (TECNEMAB K1) is a diagnostic agent.

Key facts

INN anti-melanoma mab fragments
Brand TECNEMAB K1
Mechanism Diagnostic agent
Therapeutic class Various (V09)
ATC code V09IA02

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
EMA withdrawn

Pipeline programs

  1. ABP 206 Phase 3 · Amgen · Melanoma
  2. Atezolizumab Phase 3 · HOFFMANN-LA ROCHE · Melanoma
  3. Bempegaldesleukin Phase 3 · Nektar Therapeutics UK · Melanoma
  4. CMP-001 Phase 3 · Regeneron UK · Melanoma
  5. Fianlimab Phase 3 · Regeneron UK · Melanoma
  6. GSK 2132231A Phase 3 · GSK Glaxo Smith · Melanoma
  7. IOV-MEL-301 Phase 3 · Iovance Biotherapeutics · Melanoma
  8. Ipilimumab Phase 3 · Bristol Myers Squibb · Melanoma

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is anti-melanoma mab fragments?

anti-melanoma mab fragments (TECNEMAB K1) is a diagnostic agent.

What is the brand name for anti-melanoma mab fragments?

TECNEMAB K1 is a marketed brand name for anti-melanoma mab fragments. Check FDA Drugs@FDA for the current US label holder and prescribing information.